Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
3.
J AOAC Int ; 82(4): 923-8, 1999.
Article in English | MEDLINE | ID: mdl-10490320

ABSTRACT

This paper presents results of a collaborative trial study (IUPAC project No. 650/93/97) involving 29 laboratories in 13 countries applying a method for detecting genetically modified organisms (GMOs) in food. The method is based on using the polymerase chain reaction to determine the 35S promotor and the NOS terminator for detection of GMOs. reference materials were produced that were derived from genetically modified soy beans and maize. Correct identification of samples containing 2% GMOs is achievable for both soy beans and maize. For samples containing 0.5% genetically modified soy beans, analysis of the 35S promotor resulted also in a 100% correct classification. However, 3 false-negative results (out of 105 samples analyzed) were reported for analysis of the NOS terminator, which is due to the lower sensitivity of this method. Because of the bigger genomic DNA of maize, the probability of encountering false-negative results for samples containing 0.5% GMOs is greater for maize than for soy beans. For blank samples (0% GMO), only 2 false-positive results for soy beans and one for maize were reported. These results appeared as very weak signals and were most probably due to contamination of laboratory equipment.


Subject(s)
Food Analysis , Genetic Engineering , Glycine max/genetics , Plants, Genetically Modified , Polymerase Chain Reaction , Zea mays/genetics , Agrobacterium tumefaciens/genetics , Caulimovirus/genetics , Electrophoresis, Polyacrylamide Gel , False Negative Reactions , False Positive Reactions , Promoter Regions, Genetic , Terminator Regions, Genetic
4.
Nat Biotechnol ; 17(8): 733, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10429262
5.
Environ Sci Pollut Res Int ; 5(2): 89-93, 1998.
Article in English | MEDLINE | ID: mdl-19005817

ABSTRACT

The risk assessment of genetically-modified plants pursuant to Annex II B of EU Directive 94/15/EC assumes that it is possible to infer the environmental impacts of a crop plant from its characteristics, so most of Annex II should also be applicable to conventional plants. To test this, we surveyed reports on the ecological impacts of the cultivation of non-transgenic crop plants with novel or improved traits and, in three cases, investigated whether Annex II B would have been adequate to indicate the effects. Such an assessment appears to be feasible only if the time frame on which it is based is short, so that long-term effects cannot be assessed. Secondly, the plant must be genetically homogenous which is not always granted, e.g. with forest-trees. Thirdly, the cultivation area must be defined. Differences in the behaviour of foreign plants between their original and cultivation habitats may be ecologically relevant and should be assessed. In the (few) cases where direct inference of the observed effects was possible from inherent traits, these effects often correlated with poor adaptation to local environmental conditions. The ecological impacts of traits that had been introduced in order to overcome poor adaptation may differ widely according to the way in which the traits are exploited. In practice, the effects of agricultural measures are more important than the effects of gene transfer and invasiveness, although the latter currently play a major role in risk assessment. In the light of these deliberations, a modification of Annex II B of EU Directive 94/15/EC is suggested.

6.
J Biol Chem ; 267(16): 11267-73, 1992 Jun 05.
Article in English | MEDLINE | ID: mdl-1597461

ABSTRACT

A novel cDNA clone termed E16 which codes for an integral membrane protein of 241 amino acids with six transmembrane domains was isolated from peripheral blood lymphocytes. The cDNA clone is 4000 base pairs in length and exhibits an unusually long 3'-untranslated region of about 3000 nucleotides. Its expression at the mRNA level is closely linked to cellular activation and division. In all myeloid and lymphoid cells, as well as in primary lymphocytes from peripheral blood, E16 transcripts are rapidly induced and rapidly degraded after stimulation. This pattern of expression is unusual for an integral membrane protein and resembles more closely the kinetic seen for protooncogenes and lymphokines in the T cell system. Its isolation was made possible by a novel approach especially designed to selectively clone cDNAs which exhibit such an expression kinetic. It is based on a combination of the differential screening of a subtracted cDNA library and the subsequent hybridization of the resulting phages to a short oligonucleotide (5'-TAAATAAA-TAAATA-3'). This oligonucleotide is complementary to a trimer of the rapid degradation signal (AUUUA) which is present as a single or reiterated motif in the 3'-untranslated region of many short-lived transcripts.


Subject(s)
Membrane Proteins/genetics , Amino Acid Sequence , Base Sequence , Blotting, Northern , Cloning, Molecular , Cytokines/genetics , DNA/genetics , Ionomycin/pharmacology , Kinetics , Lymphocytes/drug effects , Molecular Sequence Data , Nucleic Acid Hybridization , Proto-Oncogenes , RNA, Messenger/genetics , Restriction Mapping , Tetradecanoylphorbol Acetate/pharmacology
7.
Eur J Immunol ; 21(2): 377-83, 1991 Feb.
Article in English | MEDLINE | ID: mdl-1842498

ABSTRACT

A novel cDNA clone termed R2 was isolated by subtractive hybridization of a cDNA library of phytohemagglutinin (PHA)/phorbol myristate acetate-stimulated Jurkat cells and by rescreening a cDNA library of PHA-stimulated peripheral blood lymphocytes. It hybridizes to a single mRNA species of about 2.2 kb, which is inducible in lymphoid cells and codes for a protein of 267 amino acids which contains four potential transmembrane domains. A computer-aided comparison showed strong homology to four other membrane proteins, the pan B cell marker CD37, the pan leukocyte marker CD53, the melanoma antigen ME491 and, surprisingly, the Schistosoma mansoni antigen Sm23. The four human proteins share a number of additional similarities in their overall structure. These include identical spacing of the transmembrane domains, similar hydrophobicity plots, possible N-linked glycosylation sites of similar number and position as well as similar distribution of the cysteine residues. The majority of these characteristics are still conserved in the evolutionary most distant member of this family, the Schistosoma mansoni antigen Sm23. Here we introduce this new protein superfamily and characterize the inducible, lymphoid-specific member R2.


Subject(s)
Antigens, Differentiation/genetics , Antigens, Helminth/genetics , Membrane Glycoproteins , Proto-Oncogene Proteins , Schistosoma mansoni/immunology , Amino Acid Sequence , Animals , Antigens, CD/genetics , Antigens, Differentiation, T-Lymphocyte/genetics , Antigens, Neoplasm/genetics , B-Lymphocytes/immunology , Base Sequence , Cloning, Molecular , Glycoproteins/genetics , Humans , Kangai-1 Protein , Lymphocyte Activation/immunology , Melanoma/immunology , Molecular Sequence Data , Multigene Family , Platelet Membrane Glycoproteins/genetics , RNA, Messenger/biosynthesis , Sequence Homology, Nucleic Acid , T-Lymphocytes/immunology , Tetraspanin 25 , Tetraspanin 30 , Tetraspanins , Up-Regulation
8.
J Exp Med ; 171(5): 1431-42, 1990 May 01.
Article in English | MEDLINE | ID: mdl-2139695

ABSTRACT

We present here the molecular characterization of a new activation-induced surface structure on human T lymphocytes, termed LA45, with high homology (93% at protein level) to MHC class I molecules. Antigen modulation and sequential immunoprecipitation experiments revealed that LA45 and HLA class I proteins do not crossreact with the corresponding antibodies. Furthermore, LA45 is not associated with beta 2-m. On the other hand, we could show that the separation of HLA-A,B,C and beta 2m molecules, induced by SDS-denaturation, leads to a conformational change in the heavy chain in such a way that it becomes reactive with LA45. The 90/45 kD LA45 proteins thus appear to be non-beta 2m-associated MHC class I alpha chains that are selectively expressed by activated but not by resting human T lymphocytes.


Subject(s)
Antigens, CD/analysis , Histocompatibility Antigens Class I/analysis , Lymphocyte Activation , T-Lymphocytes/immunology , beta 2-Microglobulin/analysis , Amino Acid Sequence , Antibodies, Monoclonal , Antigens, Differentiation, T-Lymphocyte/analysis , Base Sequence , Blotting, Western , CD3 Complex , Cells, Cultured , Cloning, Molecular , Histocompatibility Antigens Class I/genetics , Humans , Macromolecular Substances , Molecular Sequence Data , Receptors, Antigen, T-Cell/analysis , Sequence Homology, Nucleic Acid
9.
EMBO J ; 6(12): 3673-7, 1987 Dec 01.
Article in English | MEDLINE | ID: mdl-3322813

ABSTRACT

Human glioblastoma cells secrete a peptide, termed glioblastoma-derived T cell suppressor factor (G-TsF), which has suppressive effects on interleukin-2-dependent T cell growth. As shown here, complementary DNA for G-TsF reveals that G-TsF shares 71% amino acid homology with transforming growth factor-beta (TGF-beta). In analogy to TGF-beta it is apparently synthesized as the carboxy-terminal end of a precursor polypeptide which undergoes proteolytic cleavage to yield the 112 amino-acid-long mature form of G-TsF. Comparison of the amino-terminal sequence of G-TsF with that of porcine TGF-beta 2 and bovine cartilage-inducing factor B shows complete homology, which indicates that we have cloned the human analogue of these factors. It is tempting to consider a role for G-TsF in tumor growth where it may enhance tumor cell proliferation in an autocrine way and/or reduce immunosurveillance of tumor development.


Subject(s)
DNA/metabolism , Glioma/genetics , Neoplasm Proteins/genetics , Peptides/genetics , Suppressor Factors, Immunologic/genetics , T-Lymphocytes/immunology , Amino Acid Sequence , Base Sequence , Cell Line , Cloning, Molecular , Genes , Glioma/immunology , Humans , Molecular Sequence Data , Peptides/immunology , Transforming Growth Factor beta , Transforming Growth Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...